Sun Pharmaceuticals Industries Ltd Nine Monthly Results

Gross Sales

35,945.12

32,553.3

29,040.34

24,769.34

24,247.14

Excise Duty

0

0

0

0

0

Net Sales

35,945.12

32,553.3

29,040.34

24,769.34

24,247.14

Other Operating Income

568.83

401.71

167.39

205.82

405.42

Other Income

748.25

261.24

807.92

1,012.8

533.75

Total Income

37,262.2

33,216.25

30,015.65

25,987.96

25,186.31

Total Expenditure

26,918.65

24,110.35

21,781.45

22,165.56

19,025.81

PBIDT

10,343.55

9,105.9

8,234.2

3,822.4

6,160.5

Interest

164.9

79.26

90.01

111.33

250.95

PBDT

10,178.65

9,026.64

8,144.19

3,711.07

5,909.55

Depreciation

1,906.28

1,857.9

1,587.27

1,526.46

1,477.4

Minority Interest Before NP

0

0

0

0

0

Tax

1,290.52

624.68

928.74

747.93

739.71

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

6,981.85

6,544.06

5,628.18

1,436.68

3,692.44

Minority Interest After NP

29.49

40.93

66.68

-579.73

314.11

Net Profit after Minority Interest

6,921.8

6,489.11

5,549.98

2,009.67

3,365.09

Extra-ordinary Items

-331.42

0

-541.68

-1,912.03

0

Adjusted Profit After Extra-ordinary item

7,253.22

6,489.11

6,091.66

3,921.7

3,365.09

EPS (Unit Curr.)

28.8

27

23.1

8.38

14.03

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

850

750

700

550

300

Equity

239.93

239.93

239.93

239.93

239.93

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

28.77

27.97

28.35

15.43

25.4

PBDTM(%)

28.31

27.72

28.04

14.98

24.37

PATM(%)

19.42

20.1

19.38

5.8

15.22